VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,691 | -55.7% | 1,354,400 | +15.9% | 0.02% | -46.3% |
Q2 2023 | $28,653 | +6.1% | 1,168,100 | +0.7% | 0.04% | +13.9% |
Q1 2023 | $27,005 | +0.8% | 1,160,500 | +9.6% | 0.04% | -2.7% |
Q4 2022 | $26,788 | -99.9% | 1,058,400 | -30.0% | 0.04% | -9.8% |
Q3 2022 | $29,161,000 | +103.6% | 1,512,494 | +168.9% | 0.04% | +141.2% |
Q2 2022 | $14,324,000 | +490.0% | 562,400 | +495.8% | 0.02% | +466.7% |
Q1 2022 | $2,428,000 | +0.2% | 94,400 | +63.0% | 0.00% | 0.0% |
Q4 2021 | $2,424,000 | -36.0% | 57,900 | -27.7% | 0.00% | -40.0% |
Q2 2021 | $3,787,000 | +88.9% | 80,102 | +36.9% | 0.01% | +150.0% |
Q1 2020 | $2,005,000 | – | 58,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $38,245,753 | 30.44% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $409,259,526 | 3.12% |
Octagon Capital Advisors LP | 650,100 | $15,946,953 | 2.22% |
Paradigm Biocapital Advisors LP | 1,014,239 | $24,879,283 | 1.92% |
Perceptive Advisors | 1,958,264 | $48,036,216 | 1.39% |
Avidity Partners Management LP | 1,425,000 | $34,955,250 | 1.22% |
Ghost Tree Capital, LLC | 150,000 | $3,679,500 | 1.22% |
MIRABELLA FINANCIAL SERVICES LLP | 412,008 | $10,106,556 | 1.11% |
SECTOR GAMMA AS | 150,406 | $3,689,459 | 0.83% |
Sofinnova Investments, Inc. | 488,117 | $11,973,510 | 0.78% |